In hepatocellular carcinoma, PCNA, along with cell cycle regulators GTSE1, CDC20, and MCM6, was found to drive tumor progression and predict poor prognosis, establishing PCNA as a potential molecular biomarker for liver cancer (Zheng et al., 2019). The gene discussed is PCNA; the disease is neoplasm.